Predictors of response to ziprasidone: results from a 6-week randomized double-blind, placebo-controlled trial for acute depressive mixed state. [electronic resource]
- Pharmacopsychiatry Jun 2012
- 152-5 p. digital
Adolescent Adult Aged Analysis of Variance Antipsychotic Agents--therapeutic use Depressive Disorder--drug therapy Double-Blind Method Female Humans Male Middle Aged Piperazines--therapeutic use Predictive Value of Tests Prospective Studies Psychiatric Status Rating Scales Thiazoles--therapeutic use Treatment Outcome Young Adult